Related Experiment Video
Updated: Sep 5, 2025

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
Crystal structure of the catalytic domain of human RPTPH
Myeongbin Kim1, Seong Eon Ryu1
1Department of Bioengineering, College of Engineering, Hanyang University, Seoul 04673, Republic of Korea.
Abstract:
Receptor-type protein tyrosine phosphatases (RPTPs) receive extracellular stimuli and transfer them into cells. They regulate cell growth, differentiation and death via specific signals. They have also been implicated in cancer, diabetes and neurological diseases. RPTPH, a member of the type 3 RPTP (R3-PTP) family, is an important regulator of colorectal cancer and hepatic carcinoma. Despite its importance in drug development, the structure of RPTPH has not yet been resolved. Here, the crystal structure of the catalytic domain of RPTPH was determined at 1.56 Å resolution. Despite similarities to other R3-PTPs in its overall structure, RPTPH exhibited differences in its loop regions and side-chain conformations. Compared with other R3-PTPs, RPTPH has unique side chains near its active site that may confer specificity for inhibitor binding. Therefore, detailed information on the structure of RPTPH provides clues for the development of specific inhibitors.
Insights
Researchers determined the crystal structure of the RPTPH protein, revealing unique features near its active site. This structural information is crucial for developing targeted therapies for cancers like colorectal and hepatic carcinoma.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- Receptor-type protein tyrosine phosphatases (RPTPs) are key signaling molecules involved in cellular processes.
- Dysregulation of RPTPs is linked to diseases including cancer, diabetes, and neurological disorders.
- RPTPH, a type 3 RPTP (R3-PTP), plays a significant role in colorectal and hepatic cancers.
Purpose of the Study:
- To elucidate the three-dimensional structure of the catalytic domain of RPTPH.
- To identify structural differences between RPTPH and other R3-PTPs.
- To provide insights for the development of RPTPH-specific inhibitors for cancer therapy.
Main Methods:
- X-ray crystallography was employed to determine the structure of the RPTPH catalytic domain.
- The structure was resolved at a resolution of 1.56 Å.
- Comparative analysis of RPTPH structure with other R3-PTPs was performed.
Main Results:
- The crystal structure of the RPTPH catalytic domain was successfully determined.
- RPTPH shares overall structural similarity with other R3-PTPs but exhibits distinct loop regions and side-chain conformations.
- Unique side chains were identified in the vicinity of the RPTPH active site.
Conclusions:
- The determined structure of RPTPH provides a detailed molecular understanding of this important protein.
- Structural variations, particularly near the active site, suggest potential for developing highly specific RPTPH inhibitors.
- This structural data is valuable for future drug development targeting RPTPH in cancer treatment.
Related Concept Videos
ATP Synthase: Structure
Receptor Tyrosine Kinases
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...

